Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rayner

Showing results (391-400 of 422) with videos related to

Pageof 43
Sort By:
The Kaohsiung Journal of Medical Sciences|May 18, 2016
Associated factors in Streptococcus bovis bacteremia and colorectal cancerCheng-En Tsai, Cheng-Tang Chiu, Christopher K Rayner, et al.
Diabetes, Obesity & Metabolism|January 10, 2019
Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetesKaren L Jones, Rachael S Rigda, Madeline D M Buttfield, et al.
Diabetes|April 8, 2017
Mechanisms Controlling Glucose-Induced GLP-1 Secretion in Human Small IntestineEmily W Sun, Dayan de Fontgalland, Philippa Rabbitt, et al.
Diabetes & Vascular Disease Research|December 13, 2016
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Diabetes|January 6, 2025
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover StudyDaniel R Quast, Cong Xie, Michelle J Bound, et al.
Diabetes Care|July 10, 2013
The effect of exogenous glucose-dependent insulinotropic polypeptide in combination with glucagon-like peptide-1 on glycemia in the critically illMichael Y Lee, Jonathan D Fraser, Marianne J Chapman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2020
Acceleration of Gastric Emptying by Insulin-Induced Hypoglycemia is Dependent on the Degree of HypoglycemiaTejaswini Arunachala Murthy, Jacqueline Grivell, Seva Hatzinikolas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2022
Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingChinmay S Marathe, Hung Pham, Tongzhi Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2009
Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemiaAdam M Deane, Nam Q Nguyen, Julie E Stevens, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 11, 2006
The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposedTanya J Little, Selena Doran, James H Meyer, et al.
Pageof 43

Showing results (391-400 of 422) with videos related to

Sort By:
Pageof 43
The Kaohsiung Journal of Medical Sciences|May 18, 2016
Associated factors in Streptococcus bovis bacteremia and colorectal cancerCheng-En Tsai, Cheng-Tang Chiu, Christopher K Rayner, et al.
Diabetes, Obesity & Metabolism|January 10, 2019
Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetesKaren L Jones, Rachael S Rigda, Madeline D M Buttfield, et al.
Diabetes|April 8, 2017
Mechanisms Controlling Glucose-Induced GLP-1 Secretion in Human Small IntestineEmily W Sun, Dayan de Fontgalland, Philippa Rabbitt, et al.
Diabetes & Vascular Disease Research|December 13, 2016
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Diabetes|January 6, 2025
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover StudyDaniel R Quast, Cong Xie, Michelle J Bound, et al.
Diabetes Care|July 10, 2013
The effect of exogenous glucose-dependent insulinotropic polypeptide in combination with glucagon-like peptide-1 on glycemia in the critically illMichael Y Lee, Jonathan D Fraser, Marianne J Chapman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2020
Acceleration of Gastric Emptying by Insulin-Induced Hypoglycemia is Dependent on the Degree of HypoglycemiaTejaswini Arunachala Murthy, Jacqueline Grivell, Seva Hatzinikolas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2022
Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingChinmay S Marathe, Hung Pham, Tongzhi Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2009
Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemiaAdam M Deane, Nam Q Nguyen, Julie E Stevens, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 11, 2006
The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposedTanya J Little, Selena Doran, James H Meyer, et al.
Pageof 43